The use of intravenous tPA for the treatment of severe frostbite
Highlights • Intravenous tPA has a role in the treatment of severe frostbite. • Consider anti-platelet therapy for patients in whom Coumadin is contra-indicated. • Protocol for IV tPA and anti-platelet therapy from one institution is reviewed.
Gespeichert in:
Veröffentlicht in: | Burns 2017-08, Vol.43 (5), p.1088-1096 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1096 |
---|---|
container_issue | 5 |
container_start_page | 1088 |
container_title | Burns |
container_volume | 43 |
creator | Jones, Larry M Coffey, Rebecca A Natwa, Mona P Bailey, J. Kevin |
description | Highlights • Intravenous tPA has a role in the treatment of severe frostbite. • Consider anti-platelet therapy for patients in whom Coumadin is contra-indicated. • Protocol for IV tPA and anti-platelet therapy from one institution is reviewed. |
doi_str_mv | 10.1016/j.burns.2017.01.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1865520609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030541791730027X</els_id><sourcerecordid>1865520609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-b51c5fa176c50b621c73b0f803a5ac4ba8345cd7078ed688139bfb4b1a50819c3</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhkVJabZpf0Gh-JiLNzOWZcmHhoaQJoVAA0kgNyHJY6qt104leSH_vnI3zSGXigEd5n3n4xnGPiGsEbA52aztHMa4rgDlGjAHf8NWqGRbYg3tAVsBB1HWKNtD9j7GDeQnFLxjh5VC0aLAFft695OKOVIx9YUfUzA7Gqc5FunmrOinUKScToFM2tKYFlGkHQUq-jDFZH2iD-xtb4ZIH5__I3b_7eLu_Kq8_nH5_fzsunS8Fam0Ap3oDcrGCbBNhU5yC70CboRxtTWK18J1EqSirlEKeWt7W1s0AhS2jh-x433dxzD9nikmvfXR0TCYkfLAGlUjRAUNtFnK91KXh4yBev0Y_NaEJ42gF3R6o_-i0ws6DZiDZ9fn5waz3VL34vnHKgu-7AWU19x5Cjo6T6OjzgdySXeT_0-D01d-N_jROzP8oieKmyk7MkGNOlYa9O1yveV4KDlAJR_4H8tflKY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865520609</pqid></control><display><type>article</type><title>The use of intravenous tPA for the treatment of severe frostbite</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Jones, Larry M ; Coffey, Rebecca A ; Natwa, Mona P ; Bailey, J. Kevin</creator><creatorcontrib>Jones, Larry M ; Coffey, Rebecca A ; Natwa, Mona P ; Bailey, J. Kevin</creatorcontrib><description>Highlights • Intravenous tPA has a role in the treatment of severe frostbite. • Consider anti-platelet therapy for patients in whom Coumadin is contra-indicated. • Protocol for IV tPA and anti-platelet therapy from one institution is reviewed.</description><identifier>ISSN: 0305-4179</identifier><identifier>EISSN: 1879-1409</identifier><identifier>DOI: 10.1016/j.burns.2017.01.013</identifier><identifier>PMID: 28159151</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Administration, Intravenous ; Adult ; Aged ; Anti-platelet therapy ; Anticoagulants - therapeutic use ; Critical Care ; Female ; Fibrinolytic Agents - administration & dosage ; Frostbite ; Frostbite - drug therapy ; Humans ; Intravenous tPA ; Male ; Middle Aged ; Platelet Aggregation Inhibitors - therapeutic use ; Thrombolytic Therapy - methods ; Tissue Plasminogen Activator - administration & dosage ; Warfarin - therapeutic use ; Young Adult</subject><ispartof>Burns, 2017-08, Vol.43 (5), p.1088-1096</ispartof><rights>Elsevier Ltd and ISBI</rights><rights>2017 Elsevier Ltd and ISBI</rights><rights>Copyright © 2017 Elsevier Ltd and ISBI. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-b51c5fa176c50b621c73b0f803a5ac4ba8345cd7078ed688139bfb4b1a50819c3</citedby><cites>FETCH-LOGICAL-c395t-b51c5fa176c50b621c73b0f803a5ac4ba8345cd7078ed688139bfb4b1a50819c3</cites><orcidid>0000-0001-9004-678X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S030541791730027X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28159151$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jones, Larry M</creatorcontrib><creatorcontrib>Coffey, Rebecca A</creatorcontrib><creatorcontrib>Natwa, Mona P</creatorcontrib><creatorcontrib>Bailey, J. Kevin</creatorcontrib><title>The use of intravenous tPA for the treatment of severe frostbite</title><title>Burns</title><addtitle>Burns</addtitle><description>Highlights • Intravenous tPA has a role in the treatment of severe frostbite. • Consider anti-platelet therapy for patients in whom Coumadin is contra-indicated. • Protocol for IV tPA and anti-platelet therapy from one institution is reviewed.</description><subject>Administration, Intravenous</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-platelet therapy</subject><subject>Anticoagulants - therapeutic use</subject><subject>Critical Care</subject><subject>Female</subject><subject>Fibrinolytic Agents - administration & dosage</subject><subject>Frostbite</subject><subject>Frostbite - drug therapy</subject><subject>Humans</subject><subject>Intravenous tPA</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Thrombolytic Therapy - methods</subject><subject>Tissue Plasminogen Activator - administration & dosage</subject><subject>Warfarin - therapeutic use</subject><subject>Young Adult</subject><issn>0305-4179</issn><issn>1879-1409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1r3DAQhkVJabZpf0Gh-JiLNzOWZcmHhoaQJoVAA0kgNyHJY6qt104leSH_vnI3zSGXigEd5n3n4xnGPiGsEbA52aztHMa4rgDlGjAHf8NWqGRbYg3tAVsBB1HWKNtD9j7GDeQnFLxjh5VC0aLAFft695OKOVIx9YUfUzA7Gqc5FunmrOinUKScToFM2tKYFlGkHQUq-jDFZH2iD-xtb4ZIH5__I3b_7eLu_Kq8_nH5_fzsunS8Fam0Ap3oDcrGCbBNhU5yC70CboRxtTWK18J1EqSirlEKeWt7W1s0AhS2jh-x433dxzD9nikmvfXR0TCYkfLAGlUjRAUNtFnK91KXh4yBev0Y_NaEJ42gF3R6o_-i0ws6DZiDZ9fn5waz3VL34vnHKgu-7AWU19x5Cjo6T6OjzgdySXeT_0-D01d-N_jROzP8oieKmyk7MkGNOlYa9O1yveV4KDlAJR_4H8tflKY</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Jones, Larry M</creator><creator>Coffey, Rebecca A</creator><creator>Natwa, Mona P</creator><creator>Bailey, J. Kevin</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9004-678X</orcidid></search><sort><creationdate>20170801</creationdate><title>The use of intravenous tPA for the treatment of severe frostbite</title><author>Jones, Larry M ; Coffey, Rebecca A ; Natwa, Mona P ; Bailey, J. Kevin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-b51c5fa176c50b621c73b0f803a5ac4ba8345cd7078ed688139bfb4b1a50819c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Administration, Intravenous</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-platelet therapy</topic><topic>Anticoagulants - therapeutic use</topic><topic>Critical Care</topic><topic>Female</topic><topic>Fibrinolytic Agents - administration & dosage</topic><topic>Frostbite</topic><topic>Frostbite - drug therapy</topic><topic>Humans</topic><topic>Intravenous tPA</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Thrombolytic Therapy - methods</topic><topic>Tissue Plasminogen Activator - administration & dosage</topic><topic>Warfarin - therapeutic use</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Larry M</creatorcontrib><creatorcontrib>Coffey, Rebecca A</creatorcontrib><creatorcontrib>Natwa, Mona P</creatorcontrib><creatorcontrib>Bailey, J. Kevin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Burns</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Larry M</au><au>Coffey, Rebecca A</au><au>Natwa, Mona P</au><au>Bailey, J. Kevin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of intravenous tPA for the treatment of severe frostbite</atitle><jtitle>Burns</jtitle><addtitle>Burns</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>43</volume><issue>5</issue><spage>1088</spage><epage>1096</epage><pages>1088-1096</pages><issn>0305-4179</issn><eissn>1879-1409</eissn><abstract>Highlights • Intravenous tPA has a role in the treatment of severe frostbite. • Consider anti-platelet therapy for patients in whom Coumadin is contra-indicated. • Protocol for IV tPA and anti-platelet therapy from one institution is reviewed.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28159151</pmid><doi>10.1016/j.burns.2017.01.013</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9004-678X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-4179 |
ispartof | Burns, 2017-08, Vol.43 (5), p.1088-1096 |
issn | 0305-4179 1879-1409 |
language | eng |
recordid | cdi_proquest_miscellaneous_1865520609 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Administration, Intravenous Adult Aged Anti-platelet therapy Anticoagulants - therapeutic use Critical Care Female Fibrinolytic Agents - administration & dosage Frostbite Frostbite - drug therapy Humans Intravenous tPA Male Middle Aged Platelet Aggregation Inhibitors - therapeutic use Thrombolytic Therapy - methods Tissue Plasminogen Activator - administration & dosage Warfarin - therapeutic use Young Adult |
title | The use of intravenous tPA for the treatment of severe frostbite |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A12%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20intravenous%20tPA%20for%20the%20treatment%20of%20severe%20frostbite&rft.jtitle=Burns&rft.au=Jones,%20Larry%20M&rft.date=2017-08-01&rft.volume=43&rft.issue=5&rft.spage=1088&rft.epage=1096&rft.pages=1088-1096&rft.issn=0305-4179&rft.eissn=1879-1409&rft_id=info:doi/10.1016/j.burns.2017.01.013&rft_dat=%3Cproquest_cross%3E1865520609%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1865520609&rft_id=info:pmid/28159151&rft_els_id=S030541791730027X&rfr_iscdi=true |